Please login to the form below
David Nicholson to step down as head of England’s NHS
Decision to retire comes two months after publication of Francis report into hospital scandal
Roche repeats cancer drugs warning as Avastin faces another NICE rejection
Concerns about future of Cancer Drugs Fund
Italian pharma market set for continued downturn
Will fall $1.6bn in value by 2020, say analysts GlobalData
Novartis wins third NICE recommendation for Lucentis
Gains final backing to treat NHS patients with macular oedema
France ignores EMA and suspends Bayer's Diane 35
National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict
ClinTec International expands into Turkey
CRO says new office will bolster its presence in the Middle East and North Africa
Royalty Pharma raises Elan bid as deals keep coming
Values Elan at about $6.5bn
Pfizer pulls late-stage trial of cancer drug in NHL
Inotuzumab ozogamicin fails to show survival benefit in phase III
Actavis to buy Warner Chilcott in $8.5bn deal
Combined company will have annual revenues of about $11bn
Informational source shift: from marketing to medical
The changing role of medical information in HCP communications pathways
-
Chasing the cure for Parkinson's diseaseResearch for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms
-
From paralysis to analysis: the journey to multichannel marketingTo make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier
-
Healthcare at Home and QED partner on orphan diseases
OrphanReach alliance will see companies provide product lifecycle services
-
New vortioxetine studies reinforce efficacy in depressionSupports marketing applications from Takeda and Lundbeck
-
India puts cost controls on medicinesDrugs (Prices Control) Order 2013 reduces price of hundreds of drugs
-
Sanofi reconsiders closure plans in Toulouse after government pressureReport says research site can remain open with minimal job losses
-
PMEA 2013 opens for entryProgramme recognises responsible marketing and business practice in the healthcare industry
-
EMA says Bayer's Diane 35 should remain on European marketAgency investigation concludes acne treatment's benefits outweigh its risks
-
J&J's Simponi wins FDA approval in ulcerative colitisAdds to rheumatoid arthritis, psoriatic arthritis and active ankylosing spondylitis indications in the US
Latest appointments
-
Boehringer's Wolfram Carius to step downHe will be replaced by Wolfgang Baiker on the board of managing directors
-
Canada role for UCB's Hervé Lilliu Appointed general manager of biopharma company’s operations in the country
-
Former NICE chair joins board of biotechSir Michael Rawlins joins board of Intra-Cellular Therapeutics
-
Lundbeck's Steve Turley re-elected as EMG chairAnd Actelion's Robin Bhattacherjee retains vice-chair position
-
VC firm expands team, appoints Genzyme and Lilly veteransNew roles for James Geraghty, Steven Paul, Daniel Lynch and John Maraganore
Featured jobs
- Senior Brand Manager - Harlow
- Competitive
- Sales Manager - Media Publishing – Cheshire
- 25,000 to 35,000 per annum
- UK Marketing Director
- 80,000 to 100,000 per annum
- Group Account Director –Healthcare Advertising
- Neg
Subscribe to our email news alerts
- Achieving an aligned business intelligence capability - fact or fiction?
- Former Google chief launches online cancer forum
- Global biosimilars market to reach $2.45bn in 2013
- Value-based pricing "not in patient interest"
- Bringing trial data out of the shadows
- Novartis gets FDA green light for new Ilaris indication
- David Nicholson to step down as head of England’s NHS
- Roche repeats cancer drugs warning as Avastin faces another NICE rejection
- Italian pharma market set for continued downturn
- Novartis wins third NICE recommendation for Lucentis
- Health editor at The Sun newspaper joins Ruder Finn
- Informational source shift: from marketing to medical
PMHub
Add my companyJFK Communications, Inc
JFK Communications, Inc. is an innovative provider of creative communications solutions for the specialty pharmaceutical, biotechnology, medical technology, and allied ...
Latest intelligence
- How can pharma deliver returns on increased digital investment?
- Independent online professional networks work best as part of a multi-channel campaign ...
- The impact of Hollande's healthcare reforms in France
- A tougher environment for pharma, with market access and regulatory challenges...
- A guide to developing customer-centred, multichannel marketing
- Find out how a balanced approached to multichannel marketing could benefit your brand - the customer's agenda is just as important as Pharma's and needs to be listened to in ...
Quick links
